MERCK & CO., INC., SECURITIES, DERIVATIVE & "ERISA" LITIGATION
Case Number:
2:05-cv-01151
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Ansa Assuncao
- Butler Weihmuller
- Carella Byrne
- Cerasia Law
- Clyde & Co
- Cohn Lifland
- Duane Morris
- Elliott Greenleaf
- Entwistle & Cappucci
- Fox Rothschild
- Grant & Eisenhofer
- Greenberg Dauber
- Hughes Hubbard
- Kaufman Borgeest
- Kessler Topaz
- Landman Corsi
- Lemmon Law Firm
- Lieff Cabraser
- Lite DePalma
- Lowenstein Sandler
- Paul Weiss
- Poulos LoPiccolo
- Reitler Kailas
- Rivkin Radler
- Rogut McCarthy
- Rolnick Kramer
- Schnader Harrison
- Schulte Roth
- Schwartz Hanna
- Spivak Lipton
- Squitieri & Fearon
- Traub Lieberman
- Wilson Elser
- Windels Marx
Companies
- Amalgamated Bank
- AXA XL Ltd.
- AXIS Capital Holdings Ltd.
- Honeywell International Inc.
- Intech
- KBC Group NV
- Lord Abbett & Co. LLC
- Merck & Co. Inc.
- Nuveen LLC
- Pioneer Global Asset Management SpA
- Skandinaviska Enskilda Banken
- Zurich Insurance Group AG
Sectors & Industries:
-
May 30, 2013
Merck Investors Can't Use Vioxx News Report In Fraud MDL
A New Jersey federal judge on Wednesday allowed a class of Merck & Co. Inc. investors to tweak its securities fraud suit against the drugmaker for a sixth time but barred the inclusion of a 2004 news article, finding it didn't provide any new information about Merck's alleged knowledge of the possible risks of its painkiller Vioxx.
-
January 31, 2013
Merck Shareholders Win Cert. In Vioxx Stock Fraud MDL
A New Jersey federal judge on Wednesday certified a class of Merck & Co. Inc. investors who've claimed for years that company executives artificially boosted the drugmaker's stock price by concealing evidence that its arthritis painkiller Vioxx had been linked to heart attack risks.
-
November 09, 2011
Merck Settles ERISA Suit Over Vioxx Claims For $50M
Merck & Co. Inc. on Tuesday said it had agreed to a $49.5 million settlement in a class action alleging its employees' savings plans took a hit from the company's misrepresentations about the health risks associated with its former prescription painkiller Vioxx.
- ← Previous
- 1
- 2
- Next →